StockData

Goldenwell Biotech, Inc. (GWLL) stock

GWLLOTCFood and Kindred ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$0.65+0.05 (+8.33%)

Close on Oct 19, 2026Market cap $64.35MP/E –Yield –

Goldenwell Biotech enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Goldenwell Biotech's enterprise value was $64.34M on Oct 19, 2026, against $692.92M a year earlier. Over the last 4 years it ranged from $5.79M to $692.92M, with a median of $24.74M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Oct 19, 2026$64.34M-77.6%
2025Dec 31, 2025$287.05M+1350.1%
2024Dec 31, 2024$19.80M+241.9%
2023Dec 29, 2023$5.79M-79.5%
2022Dec 30, 2022$28.26M–

More Goldenwell Biotech figures

See a number that looks wrong?